Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 29;19(9):5436.
doi: 10.3390/ijerph19095436.

Screening for Diabetes Complications during the COVID-19 Outbreak in South Korea

Yu Shin Park  1   2 , Soo Young Kim  1   2 , Eun-Cheol Park  2   3 , Sung-In Jang  2   3
Affiliations

Screening for Diabetes Complications during the COVID-19 Outbreak in South Korea

Yu Shin Park et al. Int J Environ Res Public Health. .

Abstract

This study aimed to investigate the implementation of diabetes complications screening in South Korea during the coronavirus disease (COVID-19) outbreak. Data from the Korea Community Health Surveys conducted in 2019 and 2020 were used. This study included 51,471 participants. Multiple level analysis was used to investigate the relationships between screening for diabetic retinopathy and diabetic nephropathy and variables of both individual- and community-level factors in 2019 and 2020, before and after the COVID-19 outbreak. Diabetes nephropathy complications screening in 2020 had a lower odds ratio. However, regions heavily affected by COVID-19 showed a negative association with diabetes complications screening after the COVID-19 outbreak. For those being treated with medication for diabetes, there was a significant negative association with diabetic nephropathy screening after the outbreak. The COVID-19 outbreak was associated with a reduction in the use of diabetes nephropathy complications screening. Additionally, only regions heavily affected by COVID-19 spread showed a negative association with diabetes complications screening compared to before the COVID-19 outbreak. In this regard, it appears that many patients were unable to attend outpatient care due to COVID-19. As such, these patients should be encouraged to visit clinics for diabetes complications screening. Furthermore, alternative methods need to be developed to support these patients. Through these efforts, the development of diabetes-related complications should be prevented, and the costs associated with these complications will be reduced.

Keywords: COVID-19; diabetes; diabetic nephropathy; diabetic retinopathy.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Similar articles

See all similar articles

Cited by

References

    1. Diabetes Prevalence (% of Population Ages 20 to 79) World Bank; Washington, DC, USA: 2019.
    1. Diabetic Prevalence Trend. Statistics Korea; Seoul, Korea: 2019.
    1. Ogurtsova K., Fernandes J.D.d., Huang Y., Linnenkamp U., Guariguata L., Cho N.H., Cavan D., Shaw J.E., Makaroff L.E. Idf Diabetes Atlas: Global Estimates for the Prevalence of Diabetes for 2015 and 2040. Diabetes Res. Clin. Pract. 2017;128:40–50. doi: 10.1016/j.diabres.2017.03.024. - DOI - PubMed
    1. Zhang P., Zhang X., Brown J., Vistisen D., Sicree R., Shaw J., Nichols G. Global Healthcare Expenditure on Diabetes for 2010 and 2030. Diabetes Res. Clin. Pract. 2010;87:293–301. doi: 10.1016/j.diabres.2010.01.026. - DOI - PubMed
    1. Evans R.J., Michelessi M., Virgili G. Laser Photocoagulation for Proliferative Diabetic Retinopathy. Cochrane Database Syst. Rev. 2014;11 doi: 10.1002/14651858.CD011234.pub2. - DOI - PMC - PubMed

Publication types

MeSH terms